/FH.NE
FH.NE Stock - Filament Health Corp.
Healthcare|Drug Manufacturers - Specialty & GenericNEO
$0.01-33.33%
$0.01 (-33.33%) • May 21
52
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.89
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for FH.NE
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.01
RISK/REWARD1:NaN
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.77
52W High$0.07
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $616,678 | $2.13M | $364,500 | N/A | N/A |
| Gross Profit | $401,610 | $2.13M | $364,500 | $-914,000 | N/A |
| Gross Margin | 65.1% | 100.0% | 100.0% | N/A | N/A |
| Operating Income | $-3,669,000 | $-4,920,000 | $-5,501,000 | $-7,097,000 | $-191,000 |
| Net Income | $-4,970,000 | $-5,322,000 | $-16,466,000 | $-9,254,000 | $-191,000 |
| Net Margin | -805.9% | -249.7% | -4517.4% | N/A | N/A |
| EPS | $-0.02 | $-0.03 | $-0.10 | $-0.06 | $-0.00 |
Company Overview
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
FH.NEBeat Rate
0%
Last 6 quarters
Avg Surprise
-76.9%
EPS vs Estimate
Beats / Misses
0/3
3 met exactly
Latest EPS
$-0.00
Q1 2025
EPS Surprise History
Q2 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Mar 31, 2025 | — | $-0.00 | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.01 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.00 | — | — |
Q2 2024 | Jun 29, 2024 | — | $-0.00 | — | — |
Q2 2024 | Apr 2, 2024 | — | $-0.01 | — | — |
Q1 2024 | Mar 30, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 15, 2023 | — | $-0.01 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.01 | — | — |
Q1 2023 | Mar 31, 2023 | $-0.02 | $-0.07 | -250.0% | ✗ MISS |
Q4 2022 | Dec 31, 2022 | $-0.03 | $-0.07 | -161.6% | ✗ MISS |
Q4 2022 | Nov 10, 2022 | $-0.01 | $-0.01 | -49.9% | ✗ MISS |
Q3 2022 | Aug 15, 2022 | $-0.01 | $-0.01 | 0.0% | = MET |
Q2 2022 | May 17, 2022 | $-0.01 | $-0.01 | 0.0% | = MET |
Q1 2022 | Mar 31, 2022 | $-0.01 | $-0.01 | 0.0% | = MET |
Q4 2021 | Nov 15, 2021 | — | $-0.01 | — | — |
Q3 2021 | Aug 17, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.02 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.00 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about FH.NE
What is FH.NE's current stock price?
Filament Health Corp. (FH.NE) is currently trading at $0.01 per share. The stock has moved -33.33% today.
What is the analyst price target for FH.NE?
No analyst price targets are currently available for this stock.
What sector is Filament Health Corp. in?
Filament Health Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the NEO exchange.
What is FH.NE's market cap?
Filament Health Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does FH.NE pay dividends?
No, Filament Health Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAWKN.NE
Awakn Life Sciences Corp.
$0.10
Mkt Cap: $0.0B
BAMM.CN
Body and Mind Inc.
$0.03
Mkt Cap: $0.0B
BHNG.CN
Bhang Inc.
$0.02
Mkt Cap: $0.0B
CANN.CN
Heritage Cannabis Holdings Corp.
$0.01
Mkt Cap: $0.0B
FFNT.CN
4Front Ventures Corp.
$0.01
Mkt Cap: $0.0B
IPOT.CN
Isracann Biosciences Inc.
$0.01
Mkt Cap: $0.0B
LUFF.CN
Luff Enterprises Ltd.
$0.01
Mkt Cap: $0.0B
NBUD.CN
North Bud Farms Inc.
$0.05
Mkt Cap: $0.0B
RMC.CN
Refined Metals Corp.
$0.12
Mkt Cap: $0.0B
THC.CN
THC Biomed Intl Ltd.
$0.02
Mkt Cap: $0.0B
Explore stocks similar to FH.NE for comparison